U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085507) titled 'Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients' on July 07.
Brief Summary: Part 1 of this study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VT7208 in healthy volunteers.
Part 2 of this study will be an open-label, randomized study to characterize the effect of food on the pharmacokinetics of VT7208 in healthy volunteers.
Part 3 of this study will evaluate the safety of VT7208 as monotherapy in patients with MS.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Multiple Sclerosis
Intervention:
DRUG: VT7208
a sma...